論文

筆頭著者 国際誌
2021年5月27日

PEGylation of mRNA by Hybridization of Complementary PEG-RNA Oligonucleotides Stabilizes mRNA without Using Cationic Materials

Pharmaceutics
  • Naoto Yoshinaga
  • ,
  • Mitsuru Naito
  • ,
  • Yoshihiro Tachihara
  • ,
  • Eger Boonstra
  • ,
  • Kensuke Osada
  • ,
  • Horacio Cabral
  • ,
  • Satoshi Uchida

13
6
開始ページ
800
終了ページ
800
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.3390/pharmaceutics13060800
出版者・発行元
MDPI AG

Messenger RNA (mRNA) delivery strategies are required to protect biologically fragile mRNA from ribonuclease (RNase) attacks to achieve efficient therapeutic protein expression. To tackle this issue, most mRNA delivery systems have used cationic components, which form electrostatically driven complexes with mRNA and shield encapsulated mRNA strands. However, cationic materials interact with anionic biomacromolecules in physiological environments, which leads to unspecific reactions and toxicities. To circumvent this issue of cation-based approaches, herein, we propose a cation-free delivery strategy by hybridization of PEGylated RNA oligonucleotides with mRNA. The PEG strands on the mRNA sterically and electrostatically shielded the mRNA, improving mRNA nuclease stability 15-fold after serum incubation compared with unhybridized mRNA. Eventually, the PEGylated mRNA induced nearly 20-fold higher efficiency of reporter protein expression than unhybridized mRNA in cultured cells. This study provides a platform to establish a safe and efficient cation-free mRNA delivery system.

リンク情報
DOI
https://doi.org/10.3390/pharmaceutics13060800
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/34071840
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227728
URL
https://www.mdpi.com/1999-4923/13/6/800/pdf
ID情報
  • DOI : 10.3390/pharmaceutics13060800
  • eISSN : 1999-4923
  • PubMed ID : 34071840
  • PubMed Central 記事ID : PMC8227728

エクスポート
BibTeX RIS